Showing results (591-600 of 5,256) with videos related to
Sort By:
Pageof 526
Skinmed|June 21, 2016
Supravenous Hyperpigmentation in an HIV-Infected PatientJanet Gilmour, Duane Bates, Genevieve Olsen, et al.Plos One|December 28, 2020
Social exclusion and the perspectives of health care providers on migrants in Gauteng public health facilities, South AfricaJanine A White, Duane Blaauw, Laetitia C RispelMedical Physics|February 1, 2021
Eigencolor radiochromic film dosimetryHugo Bouchard, Ilias Billas, Anna Subiel, et al.Pain Management|March 21, 2014
Role of intravenous acetaminophen in postoperative pain managementScott B Groudine, Howard S Smith, Duane EllsworthArchives of Otolaryngology--Head & Neck Surgery|March 22, 2006
Vaccination with human papillomavirus type 16 E7 peptide with CpG oligonucleotides for prevention of tumor growth in miceKristin B Gendron, Alex Rodriguez, Duane A SewellMethods in Enzymology|August 23, 2012
Quantifying chromatin-associated interactions: the HI-FI systemDuane D Winkler, Karolin Luger, Aaron R HiebInternational Journal of Experimental Pathology|December 1, 1990
Effects of turpentine-induced inflammation on the hypoxic stimulation of intestinal Fe3+ absorption in miceK B Raja, P Duane, T J PetersIucrdata|November 7, 2022
5-Phenyl-3-(2-phosphono-eth-yl)-1,2,3-triazol-1-ium chlorideElpiniki Chachlaki, Duane Choquesillo-Lazarte, Konstantinos D DemadisResearch Involvement and Engagement|November 20, 2024
Integrating expert patients perspectives on the processes of engaging them in early medical educationJaimy Saif, Duane Mellor, David Rogers, et al.Haematologica|March 6, 2025
Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on: Targeted anti-cancer agents and risk of venous thromboembolismCatherine Duane, Siobhan Glavey, John Quinn, et al.Pageof 526